These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
515 related articles for article (PubMed ID: 15753396)
1. Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity. Dong J; Peng J; Zhang H; Mondesire WH; Jian W; Mills GB; Hung MC; Meric-Bernstam F Cancer Res; 2005 Mar; 65(5):1961-72. PubMed ID: 15753396 [TBL] [Abstract][Full Text] [Related]
2. Dictyostelium differentiation-inducing factor-3 activates glycogen synthase kinase-3beta and degrades cyclin D1 in mammalian cells. Takahashi-Yanaga F; Taba Y; Miwa Y; Kubohara Y; Watanabe Y; Hirata M; Morimoto S; Sasaguri T J Biol Chem; 2003 Mar; 278(11):9663-70. PubMed ID: 12522140 [TBL] [Abstract][Full Text] [Related]
3. Cyclin D3 is down-regulated by rapamycin in HER-2-overexpressing breast cancer cells. García-Morales P; Hernando E; Carrasco-García E; Menéndez-Gutierrez MP; Saceda M; Martínez-Lacaci I Mol Cancer Ther; 2006 Sep; 5(9):2172-81. PubMed ID: 16985050 [TBL] [Abstract][Full Text] [Related]
4. Proteasome-dependent degradation of cyclin D1 in 1-methyl-4-phenylpyridinium ion (MPP+)-induced cell cycle arrest. Bai J; Nakamura H; Ueda S; Kwon YW; Tanaka T; Ban S; Yodoi J J Biol Chem; 2004 Sep; 279(37):38710-4. PubMed ID: 15247282 [TBL] [Abstract][Full Text] [Related]
5. Anticancer activity of protocatechualdehyde in human breast cancer cells. Choi J; Jiang X; Jeong JB; Lee SH J Med Food; 2014 Aug; 17(8):842-8. PubMed ID: 24712725 [TBL] [Abstract][Full Text] [Related]
6. Proteasome inhibition-induced p38 MAPK/ERK signaling regulates autophagy and apoptosis through the dual phosphorylation of glycogen synthase kinase 3β. Choi CH; Lee BH; Ahn SG; Oh SH Biochem Biophys Res Commun; 2012 Feb; 418(4):759-64. PubMed ID: 22310719 [TBL] [Abstract][Full Text] [Related]
7. Glycogen synthase kinase 3 has a limited role in cell cycle regulation of cyclin D1 levels. Yang K; Guo Y; Stacey WC; Harwalkar J; Fretthold J; Hitomi M; Stacey DW BMC Cell Biol; 2006 Aug; 7():33. PubMed ID: 16942622 [TBL] [Abstract][Full Text] [Related]
8. CG0009, a novel glycogen synthase kinase 3 inhibitor, induces cell death through cyclin D1 depletion in breast cancer cells. Kim HM; Kim CS; Lee JH; Jang SJ; Hwang JJ; Ro S; Choi J PLoS One; 2013; 8(4):e60383. PubMed ID: 23565238 [TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells. Alao JP; Stavropoulou AV; Lam EW; Coombes RC; Vigushin DM Mol Cancer; 2006 Feb; 5():8. PubMed ID: 16504004 [TBL] [Abstract][Full Text] [Related]
10. Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells. Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H Mol Cancer Ther; 2007 Mar; 6(3):1151-8. PubMed ID: 17363508 [TBL] [Abstract][Full Text] [Related]
11. GSK3 is required for rapalogs to induce degradation of some oncogenic proteins and to suppress cancer cell growth. Koo J; Wang X; Owonikoko TK; Ramalingam SS; Khuri FR; Sun SY Oncotarget; 2015 Apr; 6(11):8974-87. PubMed ID: 25797247 [TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end-product-inhibited cell proliferation and protein expression of beta-catenin and cyclin D1 are dependent on glycogen synthase kinase 3beta in LLC-PK1 cells. Lin KH; Guh JY; Mo JF; Chiou SJ; Hwang CC; Chuang LY Arch Biochem Biophys; 2008 Sep; 477(1):27-32. PubMed ID: 18474214 [TBL] [Abstract][Full Text] [Related]
13. Regulation of Akt mRNA and protein levels by glycogen synthase kinase-3beta in adrenal chromaffin cells: effects of LiCl and SB216763. Nemoto T; Kanai T; Yanagita T; Satoh S; Maruta T; Yoshikawa N; Kobayashi H; Wada A Eur J Pharmacol; 2008 May; 586(1-3):82-9. PubMed ID: 18395711 [TBL] [Abstract][Full Text] [Related]
14. Differentiation-inducing factor-1 induces cyclin D1 degradation through the phosphorylation of Thr286 in squamous cell carcinoma. Mori J; Takahashi-Yanaga F; Miwa Y; Watanabe Y; Hirata M; Morimoto S; Shirasuna K; Sasaguri T Exp Cell Res; 2005 Nov; 310(2):426-33. PubMed ID: 16153639 [TBL] [Abstract][Full Text] [Related]
15. [Effects of glycogen synthase kinase 3β overexpression in rat and glycogen synthase kinase 3β inhibitor SB-216763 on proliferation of hepatic oval cells]. Zhong JQ; Xie YK; Ji XK; Fu JH; Wang Y; Zhang QY; Shi HQ; Shan YF Zhonghua Wai Ke Za Zhi; 2012 Nov; 50(11):1003-6. PubMed ID: 23302485 [TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-dependent proteolysis of cyclin D1 is associated with coxsackievirus-induced cell growth arrest. Luo H; Zhang J; Dastvan F; Yanagawa B; Reidy MA; Zhang HM; Yang D; Wilson JE; McManus BM J Virol; 2003 Jan; 77(1):1-9. PubMed ID: 12477805 [TBL] [Abstract][Full Text] [Related]
17. Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability. Hashemolhosseini S; Nagamine Y; Morley SJ; Desrivières S; Mercep L; Ferrari S J Biol Chem; 1998 Jun; 273(23):14424-9. PubMed ID: 9603954 [TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase 3beta induces cell cycle arrest in a cyclin D1-dependent manner in human lung adenocarcinoma cell line A549. Li JS; Zhu M; Tian D; Wang MX; Wang F; Li NP; Wu RL Sheng Li Xue Bao; 2007 Apr; 59(2):204-9. PubMed ID: 17437044 [TBL] [Abstract][Full Text] [Related]
19. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells. Ghosh JC; Altieri DC Clin Cancer Res; 2005 Jun; 11(12):4580-8. PubMed ID: 15958644 [TBL] [Abstract][Full Text] [Related]
20. Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-Cyclin D1 pathway. Ong CS; Zhou J; Ong CN; Shen HM Cancer Lett; 2010 Dec; 298(2):167-75. PubMed ID: 20655656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]